Clinical trial
Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport…
NCT00309257 · Mario Negri Institute for Pharmacological Research, Other · Completed
Key facts
| NCT number | NCT00309257 |
|---|---|
| Title | Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome |
| Official title | Effects of an Intensified Treatment With ACE-inhibitors, Angiotensin II Receptor Antagonists and Statins in Alport Syndrome |
| Lead sponsor | Mario Negri Institute for Pharmacological Research, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alport Syndrome |
| Intervention type | Drug |
| Interventions | ACE I, ATA II and Statins, Benazepril, Valsartan and Fluvastatin |
| Enrollment | 9 |
| Start date | Jan 1, 2004 |
| Primary completion | Jun 1, 2008 |
| Completion | Oct 1, 2009 |
| First posted | Mar 31, 2006 |
| Last update posted | Apr 4, 2023 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: